Start with MOTS-c alone at target dose for 1014 days, establish baseline response (measure fasting glucose, insulin sensitivity markers, and body composition changes), then introduce 5-Amino-1MQ at starting dose and titrate upward while monitoring
Insert the needle into the pinch at a 4590-degree angle (use 45 degrees if the fat layer is thin) [14]
P., & Nagaraju, K
The key difference is in dosing, as tirzepatide escalation starts at 2.5mg rather than 0.25mg, which means much larger weekly doses and faster vial consumption
After your session, drink plenty of water and enjoy your dayno special aftercare is needed
Additionally, T1D can lead to multiple comorbidities long-term, such as retinopathy, nephropathy, neuropathy, and cardiovascular disease (4, 5)